Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Our objective is based on a personalized approach of adjuvant breast radiotherapy by selecting patients according to tumor recurrence and toxicity risk.

Trial Details

NCT ID
NCT06382818
Phase
NA
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • COHORT A
  • COHORT B
  • COHORT C
  • COHORT D
Locations (sample)
  • Montpellier, France|43.61093,3.87635

Key Eligibility Criteria

  • General criteria (for all cohorts):
  • Women ≥ 18 years old.
  • Invasive breast cancer treated by conservative or radical surgery.
  • Conservative breast cancer surgery or radical mastectomy.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →